Jan. 14 at 3:49 p.m.
Filed under:
Pharmaceuticals,
Recalls
By Dow Jones Newswires
Johnson & Johnson recalled nearly 47 million units of over-the-counter medicines Friday, the latest in a string of quality-related product recalls.
J&J said the latest recall resulted from a thorough examination of manufacturing records that the company had undertaken in the wake of earlier recalls. J&J plans to continue reviewing practices at additional plants and signaled further recalls could result. Get the full story »
Dec. 17, 2010 at 2:49 p.m.
Filed under:
Government,
Health care,
Pharmaceuticals
By Reuters
The incoming chairman of the U.S. congressional committee investigating Johnson & Johnson’s recalls of consumer products Friday identified the previously unnamed third-party manufacturer behind last week’s Rolaids recall.
Rep. Darrell Issa of California, in a letter to Food and Drug Administration Commissioner Margaret Hamburg, said investigations by his staff revealed North Carolina-based Best Sweet as the company contracted by J&J to produce widely used Rolaids antacid products. Get the full story »
Nov. 24, 2010 at 11:45 a.m.
Filed under:
Pharmaceuticals,
Recalls
By Dow Jones Newswires-Wall Street Journal
Johnson & Johnson, which has been recalling a number of popular over-the-counter medicines, said Wednesday it’s withdrawing more Tylenol because of a labeling problem.
The company’s McNeil Consumer Healthcare unit is recalling nearly 9.3 million bottles of three Tylenol Cold Multi-Symptom products from drug stores and suppliers because the bottles’ front labels didn’t show they contain small amounts of alcohol from ingredients that flavor the medicine. Get the full story »